Just 800 of the 13,500 patients eligible to start receiving Wegovy, which can help obese people lose 15% of their body weight ...

Thousands of people with severe obesity are being denied access to effective treatment because the NHS rollout of the ...

The importance of this technique becomes even clearer when considering the larger context. An astonishing 100 million ...

New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no longer in shortage after nearly two years. Pharmacies that sold ...

In the research, mice were fed a high-fat diet were injected with the compound AP39, which delivers hydrogen sulfide direct to mitochondria in cells The research concluded that the treatment ...

One of the downsides of treatments such as Ozempic or Mounjaro is that even though patients wind up losing weight, they also tend to shed muscle mass. Losing too much muscle mass can be a health risk ...

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

My own experience initially led me to believe that weight loss was just a matter of commitment and a modicum of self-control.

The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide from its ...

PS makes wellness more accessible through real-life stories, first-person perspectives, and expert-backed information. Our ...

John M. Burke, MD, examines how new obesity treatments, such as GLP-1 agonists, might influence future cancer rates.